[go: up one dir, main page]

WO2014152317A3 - Méthodes de traitement d'infections de gonorrhée au moyen d'antibiotiques de quinolone - Google Patents

Méthodes de traitement d'infections de gonorrhée au moyen d'antibiotiques de quinolone Download PDF

Info

Publication number
WO2014152317A3
WO2014152317A3 PCT/US2014/027203 US2014027203W WO2014152317A3 WO 2014152317 A3 WO2014152317 A3 WO 2014152317A3 US 2014027203 W US2014027203 W US 2014027203W WO 2014152317 A3 WO2014152317 A3 WO 2014152317A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
treating
quinolone antibiotics
infection
administering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2014/027203
Other languages
English (en)
Other versions
WO2014152317A2 (fr
Inventor
Scott J. Hopkins
Joyce Sutcliffe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Melinta Subsidiary Corp
Original Assignee
Melinta Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Melinta Therapeutics Inc filed Critical Melinta Therapeutics Inc
Publication of WO2014152317A2 publication Critical patent/WO2014152317A2/fr
Publication of WO2014152317A3 publication Critical patent/WO2014152317A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne, d'une manière générale, des méthodes de traitement d'infections de gonorrhée au moyen d'antibiotiques de quinolone.
PCT/US2014/027203 2013-03-15 2014-03-14 Méthodes de traitement d'infections de gonorrhée au moyen d'antibiotiques de quinolone Ceased WO2014152317A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361790448P 2013-03-15 2013-03-15
US61/790,448 2013-03-15

Publications (2)

Publication Number Publication Date
WO2014152317A2 WO2014152317A2 (fr) 2014-09-25
WO2014152317A3 true WO2014152317A3 (fr) 2014-12-04

Family

ID=51581695

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2014/027203 Ceased WO2014152317A2 (fr) 2013-03-15 2014-03-14 Méthodes de traitement d'infections de gonorrhée au moyen d'antibiotiques de quinolone

Country Status (3)

Country Link
AR (1) AR095595A1 (fr)
TW (1) TW201444558A (fr)
WO (1) WO2014152317A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107789323B (zh) * 2016-08-31 2021-05-07 鲁南制药集团股份有限公司 一种注射用德拉沙星葡甲胺冻干制剂及其制备方法
JOP20190086A1 (ar) 2016-10-21 2019-04-18 Novartis Ag مشتقات نافثيريدينون جديدة واستخدامها في معالجة عدم انتظام ضربات القلب
BR112022018315A2 (pt) * 2020-04-02 2022-10-25 Glaxosmithkline Ip Dev Ltd Regime para tratar a infecção por neisseria gonorrhoeae com gepotidacina

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010096551A2 (fr) * 2009-02-18 2010-08-26 Rib-X Pharmaceuticals, Inc. Compositions antimicrobiennes
US20110124597A1 (en) * 2009-09-25 2011-05-26 Anacor Pharmaceuticals, Inc. Boron containing small molecules
US20120041208A1 (en) * 2008-09-24 2012-02-16 Rib-X Pharmaceuticals, Inc. Process for making quinolone compounds
US20120108582A1 (en) * 2007-01-05 2012-05-03 Daiichi Sankyo Company, Limited Fused substituted aminopyrrolidine derivative

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120108582A1 (en) * 2007-01-05 2012-05-03 Daiichi Sankyo Company, Limited Fused substituted aminopyrrolidine derivative
US20120041208A1 (en) * 2008-09-24 2012-02-16 Rib-X Pharmaceuticals, Inc. Process for making quinolone compounds
WO2010096551A2 (fr) * 2009-02-18 2010-08-26 Rib-X Pharmaceuticals, Inc. Compositions antimicrobiennes
US20110124597A1 (en) * 2009-09-25 2011-05-26 Anacor Pharmaceuticals, Inc. Boron containing small molecules

Also Published As

Publication number Publication date
TW201444558A (zh) 2014-12-01
AR095595A1 (es) 2015-10-28
WO2014152317A2 (fr) 2014-09-25

Similar Documents

Publication Publication Date Title
HK1201065A1 (en) Novel quinoxaline inhibitors of pi3k
EP4331677A3 (fr) Procédés de traitement d'infections à coronavirus félin
HK1224296A1 (zh) 布罗莫结构域抑制剂
WO2012173682A3 (fr) Composés et méthodes de traitement de maladies liées à l'isocitrate déshydrogénase
IN2014KN00948A (fr)
AU2012214029A8 (en) Rorgammat inhibitors
HRP20250119T1 (hr) Kdm1a inhibitor i njegova primjena u terapiji
MX345928B (es) Composiciones terapeuticamente activas y metodos de uso de las mismas.
WO2015002994A3 (fr) Composés hétéroaryliques pouvant être utilisés en tant qu'inhibiteurs de l'enzyme sae
WO2014031872A3 (fr) Inhibiteurs à petites molécules pour le traitement d'infections parasitaires
MX2015016421A (es) Derivados de pirazolo-pirrolidin-4-ona como inhibidores de bet y su uso en el tratamiento de enfermedades.
MX338610B (es) Composiciones farmaceuticas que comprenden sulbactam e inhibidor de beta-lactamasa.
EP4582424A3 (fr) Dérivé de 1,2-naphtoquinone et son procédé de préparation
MX2015016425A (es) Derivados de pirazolo-pirrolidin-4-ona y su uso en el tratamiento de enfermedades.
EP3312175A4 (fr) Dérivé hétéroaryle ou sel pharmaceutiquement acceptable de ce dernier, son procédé de préparation et composition pharmaceutique destinée à prévenir ou à traiter des maladies associées à des pi3 kinases, le contenant en tant que principe actif
WO2013085849A3 (fr) Esters de sulfate de noribogaïne
UA111599C2 (uk) Композиція каспофунгіну
WO2013106761A3 (fr) Agents antimicrobiens
EA032271B9 (ru) Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний
WO2014022382A3 (fr) Inhibiteurs de protéine kinase antibactérienne
HK1231390A1 (zh) 用於局部给药的药用组合物
SA518390825B1 (ar) مضاد حيوي جديد فعال من أمينو جلايكوسيد للبكتيريا المضادة لعقاقير متعددة
WO2011160020A3 (fr) Agents antibactériens de carbapénem avec activité anti-gram négatif
WO2014201016A3 (fr) Inhibiteurs de la voie moléculaire mitf
NZ706734A (en) Pharmaceutical compositions useful for the treatment or control of bacterial infections

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14769189

Country of ref document: EP

Kind code of ref document: A2

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)
122 Ep: pct application non-entry in european phase

Ref document number: 14769189

Country of ref document: EP

Kind code of ref document: A2